CC

Casdin Capital Portfolio holdings

AUM $1.1B
1-Year Return 24.98%
This Quarter Return
+8.72%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
AUM
$1.5B
AUM Growth
-$4.49M
Cap. Flow
+$16.9M
Cap. Flow %
1.13%
Top 10 Hldgs %
79.2%
Holding
40
New
5
Increased
3
Reduced
5
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SNDX icon
26
Syndax Pharmaceuticals
SNDX
$1.47B
$6.28M 0.42%
475,000
TSVT
27
DELISTED
2seventy bio
TSVT
$5.88M 0.39%
2,000,000
IPSC icon
28
Century Therapeutics
IPSC
$43.6M
$5.24M 0.35%
5,190,506
+1,978,190
+62% +$2M
FTRE icon
29
Fortrea Holdings
FTRE
$1.06B
$5.13M 0.34%
+275,000
New +$5.13M
CTNM
30
Contineum Therapeutics
CTNM
$322M
$4.35M 0.29%
296,666
TNGX icon
31
Tango Therapeutics
TNGX
$772M
$3.67M 0.24%
1,188,349
ABSI icon
32
Absci
ABSI
$368M
$2.55M 0.17%
973,260
PACB icon
33
Pacific Biosciences
PACB
$381M
$1.9M 0.13%
1,035,859
RXRX icon
34
Recursion Pharmaceuticals
RXRX
$2.01B
$1.12M 0.07%
+165,323
New +$1.12M
PRME icon
35
Prime Medicine
PRME
$663M
$1.07M 0.07%
367,175
GLUE icon
36
Monte Rosa Therapeutics
GLUE
$305M
$597K 0.04%
86,014
DNA icon
37
Ginkgo Bioworks
DNA
$660M
$358K 0.02%
36,493
KRON
38
DELISTED
Kronos Bio
KRON
$118K 0.01%
123,839
GRAL
39
GRAIL, Inc. Common Stock
GRAL
$1.33B
-350,000
Closed -$4.82M
EXAI
40
DELISTED
Exscientia Plc American Depositary Shares
EXAI
-213,900
Closed -$1.04M